Delphine Farlay
Overview
Explore the profile of Delphine Farlay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farlay D, Cornier M, Rizzo S, Cormier-Daire V, Charpie M, Pinto G, et al.
JBMR Plus
. 2025 Jan;
9(2):ziae161.
PMID: 39822213
OI, or bone brittle disease, is characterized by increased mineralization of bone matrix independently of clinical severity. So, a beneficial effect of antiresorptive treatments such as bisphosphonates (BP) is questionable....
2.
Regnier M, Leclerc A, Tenenbaum J, Desjonqueres M, Chavassieux P, Fremeaux-Bacchi V, et al.
Pediatr Nephrol
. 2024 Oct;
40(4):961-965.
PMID: 39422762
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy, related to complement dysregulation, including Factor H deficiency (FH) treated by lifelong eculizumab therapy. Its long-term tolerance is not yet fully...
3.
Malaval L, Follet H, Farlay D, Gineyts E, Rizzo S, Thomas C, et al.
Calcif Tissue Int
. 2024 May;
115(1):63-77.
PMID: 38733411
Osteopontin (OPN) and Bone Sialoprotein (BSP), abundantly expressed by osteoblasts and osteoclasts, appear to have important, partly overlapping functions in bone. In gene-knockout (KO, -/-) models of either protein and...
4.
Nguyen D, Vanden-Bossche A, Laroche N, Thomas M, Linossier M, Peyroche S, et al.
Exp Gerontol
. 2023 Nov;
184:112337.
PMID: 38006949
Aging is associated with detrimental bone loss leading to fragility fractures in both men and women. Notably, a majority of bone loss with aging is cortical, as well as a...
5.
Farlay D, Falgayrac G, Poncon C, Rizzo S, Cortet B, Chapurlat R, et al.
Bone Rep
. 2022 Oct;
17:101623.
PMID: 36213624
The differences in bone nanomechanical properties between cortical (Ct) and trabecular (Tb) bone remain uncertain, whereas knowing the respective contribution of each compartment is critical to understand the origin of...
6.
Farlay D, Rizzo S, Dempster D, Huang S, Chines A, Brown J, et al.
J Bone Miner Res
. 2022 Mar;
37(5):856-864.
PMID: 35249242
In postmenopausal women with osteoporosis, denosumab (DMAb) therapy through 10 years resulted in significantly higher degree of mineralization of bone, with a subsequent increase from years 2-3 to year 5...
7.
Falgayrac G, Farlay D, Poncon C, Behal H, Gardegaront M, Ammann P, et al.
Bone
. 2021 Jul;
153:116107.
PMID: 34260980
Bone quality is altered mainly by osteoporosis, which is treated with modulators of bone quality. Knowledge of their mechanisms of action is crucial to understand their effects on bone quality....
8.
Farlay D, Rizzo S, Ste-Marie L, Michou L, Morin S, Qiu S, et al.
J Bone Miner Res
. 2021 Jan;
36(6):1031-1041.
PMID: 33434290
Bisphosphonates (BPs) are the most widely used drugs for the treatment of osteoporosis but prolonged use of BPs might increase the risk of atypical femur fracture (AFF). There are only...
9.
Gritsaenko T, Pierrefite-Carle V, Creff G, Simoneau B, Hagege A, Farlay D, et al.
Arch Toxicol
. 2021 Jan;
95(3):1023-1037.
PMID: 33426622
Uranium is widely spread in the environment due to its natural and anthropogenic occurrences, hence the importance of understanding its impact on human health. The skeleton is the main site...
10.
Alioli C, Demesmay L, Laurencin-Dalacieux S, Beton N, Farlay D, Follet H, et al.
Biochim Biophys Acta Mol Cell Biol Lipids
. 2020 Apr;
1865(8):158715.
PMID: 32330664
Lysphosphatidic acid (LPA) is a major natural bioactive lipid mediator whose biological functions affect multiple organs. These include bone as demonstrated by global Lpar1-knockout mice (Lpar1) which present a bone...